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Abstract
Background Cognitive functioning is linked to cardiac mor-
tality and morbidity, but the mechanisms underlying this rela-
tionship are unclear.
Purpose To examine the relationship between pre-operative
cognitive functioning and post-operative inflammatory and
neuroendocrine responses in patients undergoing coronary ar-
tery bypass graft (CABG) surgery.
Methods One-hundred ninety-three outpatients were
screened to assess their cognitive function using the
Montreal Cognitive Assessment (MoCA) on average 30 days
prior to CABG surgery and provided blood samples for the
measurement of interleukin (IL)-6 and C-reactive protein
(CRP) and saliva samples for the measurement of diurnal
cortisol. Participants were followed-up 4–8 days following
surgery for the repeat measurement of IL-6 and CRP and
60 days after surgery for the measurement of diurnal salivary
cortisol.
Results Patients with low cognitive function (MoCA<26)
prior to surgery reached higher IL-6 concentrations in the days
after surgery (β=−0.212, p=0.021) and had greater cortisol
output across the day 2 months after surgery (β=−0.179,
p=0.044).
Conclusions Low cognitive functioning is associated with a
more negative pattern of biological response to surgery, indic-
ative of poorer physical recovery. These pathways may
contribute to the links between cognitive function and cardio-
vascular pathology.
Keywords Cognition . Coronary artery bypass graft surgery .
Inflammation . Cortisol
Introduction
Cardiovascular risk factors are known to be associated with
cognitive decline [1] and dementia [2]. Conversely, low levels
of cognitive function have long been associated with greater
all-cause [3] and cardiac mortalities [4]. In particular, much
attention has been paid to cognitive function and coronary
artery bypass graft (CABG) surgery, with estimates suggest-
ing that cognitive impairment is present in approximately
35 % of patients prior to surgery [5] and in between 22.5
and 42 % of CABG patients following surgery [6, 7]. The
mechanisms linking cognitive impairment and cardiac disease
are not clearly understood but are likely to include both in-
flammatory and neuroendocrine pathways.
Whilst mixed evidence exists, inflammation is
thought to be a common causal factor in both coronary
heart disease (CHD) [8, 9] and cognitive decline [10].
CABG surgery is associated with an acute inflammatory
response. The extent of the inflammatory response is
thought largely to reflect the amount of trauma derived
from the surgical procedure itself and is associated with
a host of clinical outcomes [11, 12]. Likewise, height-
ened levels of C-reactive protein (CRP) have been as-
sociated cross sectionally with mild cognitive impair-
ment [13] and there is some evidence for a longitudinal
effect, with both CRP and interleukin (IL)-6 being as-
sociated with worsening of cognitive function in some
population studies [14–16]. However, others have not
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corroborated such findings [17]. Therefore, more work
is needed to study the direction of this effect. As yet,
the relationship between cognition and inflammation has
not been studied in a CABG population.
The hormone cortisol is also posited to be a potential
mechanism linking CHD and cognitive function. For
example, in the cardiac literature, elevated cortisol has
been linked to cardiac risk factors such as hypercholes-
terolemia, diabetes, abdominal obesity and hypertension
by some [18, 19], but not all [20], authors. There are
limited studies investigating cortisol in CABG surgery
patients, although there is some evidence that there is
heightened cortisol output in the post-operative period
[21, 22]. Cortisol has also been linked to poorer cogni-
tive function in observational and experimental studies
[23]. Associations between the area under the curve
(AUC) of cortisol and worse performance in six cogni-
tive domains have been observed in a large cohort study
[24]. Higher morning cortisol has been associated with
mild cognitive impairment and a lower global cognitive
state in older people [25]. In addition, a prospective
association has been observed, such that high morning
cortisol and a flatter slope have been associated with
poorer cognitive performance 4 years later [26]. To
date, only one study has investigated cognitive function
and cortisol in a CABG population. Mu and colleagues
[27] found that CABG patients with higher serum cor-
tisol levels in the first post-operative morning had in-
creased risk of cognitive dysfunction 7 days after
CABG surgery. However, little is known about the im-
pact of pre-existing cognitive state on later neuroendo-
crine adaptation to CABG surgery. It is possible that the
neurocognitive changes resulting in impairment to mem-
ory and concentration cause systemic changes to the
immune system via dysregulation of the hypothalamic-
pituitary-adrenal (HPA) axis. Such changes would nega-
tively affect the body’s ability to self-regulate following
a physical trauma such as CABG surgery.
One way in which to explore the relationship be-
tween cognition and these biological mechanisms is to
study the effect of pre-surgical cognitive performance
on inflammatory and cortisol responses to CABG sur-
gery. This allows the temporal relationship between cog-
nition and biomarkers to be investigated. Therefore, the
aim of the present study was to assess the prospective
association between cognitive function prior to CABG
surgery and subsequent inflammatory and neuroendo-
crine responses to surgery. Specifically, we hypothesised
that poorer cognitive function would be associated with
greater inflammatory responses to surgery, as measured
by IL-6 and CRP, and increased cortisol output in the
months following surgery, independent of mood factors
and other clinical and sociodemographic confounders.
Methods
Participants
The study used data collected in the Adjustment and Recovery
after Cardiac Surgery (ARCS) study which was designed to
investigate the causes and consequences of poor emotional
adjustment following cardiac surgery. Full details of the re-
cruitment, inclusion criteria and short-term retention of partic-
ipants into the ARCS study have been published elsewhere
[28]. Briefly, elective, first-time candidates for CABG were
recruited consecutively from a pre-surgery assessment clinic
at St. George’s Hospital, London, between January 2010 and
July 2012. In total, 249 participants completed valid baseline
questionnaires and the Montreal Cognitive Assessment
(MoCA) and gave blood samples for the measurement of IL-
6 and CRP and seven saliva samples across the course of a
single day for the measurement of diurnal cortisol.
Participants included in these analyses were the 193 CABG
surgery patients (mean age 67.46±8.81 years, 9.3 % females)
who provided complete data for all variables at baseline and
who at follow-up provided blood for the assessment of at least
one inflammatory marker and/or seven saliva samples for the
measurement of cortisol. Compared to those excluded, those
included in our analyses were more likely to be male
(χ2 = 15.74, p<0.001), but otherwise did not differ on any
other sociodemographic, biomarker or clinical variable, with
the minimal significance level (p<0.05) used as the standard
of difference. They completed baseline assessments on aver-
age 30 days prior to surgery, had blood post-operatively col-
lected between 4 and 8 days after surgery and provided post-
operative saliva samples on average 60 days after surgery.
Measures
Predictor: Cognitive Function
TheMoCA [29] was administered by the recruiting researcher
in a private room at baseline. This is a brief measure of cog-
nitive function covering the following eight cognitive do-
mains: visuospatial awareness, executive functioning, short-
term memory, attention, concentration, working memory, lan-
guage and orientation to time and place. The MoCA has ex-
cellent sensitivity in identifying mild cognitive impairment
(90 %) and very good specificity (87 %); it also has good
test-retest reliability (r=0.92, p=0.001) [29]. A maximum
of 31 points was awarded, with a cutoff for mild cognitive
impairment of <26 [29].
Outcomes: Biomarkers
To assess inflammatory activity, we analysed blood samples
collected at baseline and during the post-operative period in
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hospital. All participants provided a baseline sample, and the
majority of participants also had blood drawn on day 4 after
surgery (N=111). A small number of participants (N=5) had
blood drawn onmore than 1 day. Since there was variability in
the days on which samples were collected following surgery,
we created a summary score. This used the mean value for IL-
6 and high sensitivity (hs)-CRP on days 4, 5, 6, 7 and 8 post-
surgery. We used the mean value in order to generate a more
stable aggregate score. A 20-mL blood sample was drawn into
a serum separator tube by venipuncture. Post-operative bloods
were collected between 6:00 and 7:00 a.m. by nursing staff.
Blood was allowed to clot and centrifuged for 10 min at
3000 rpm. The resulting serum was frozen at −80 °C until
batch analysis at a later date. Assays were performed by Dr
David Gaze at St George’s Healthcare NHS Trust, using com-
mercial automated immunoassay on the Immulite 1 (Siemens
Healthcare Diagnostics, Frimley, Surrey). For IL-6, the mini-
mal detectable dose was 2.0 pg/mL, the upper limit of detec-
tion was 1000.0 pg/mL and the intra-assay CV range was 3.5–
6.2 %. For hs-CRP, the minimal detectable dose was 0.01 mg/
dL, the upper limit of detection was 15 mg/dL and the intra-
assay CV range was 4.2–6.4 %.
Saliva samples were collected using Salivettes (Sarstedt,
Leicester, UK) for the assessment of cortisol. Cortisol sam-
pling was described to participants at baseline. The collection
procedure was identical at baseline and follow-up.
Participants were instructed to give seven samples at set time
points, on awakening, 30 min after awakening, 10:00 a.m.,
midday, 4:00 p.m., 8:00 p.m. and bedtime. Participants were
told not to eat, drink caffeinated beverages, smoke cigarettes,
take any medications or brush their teeth, for the 30 min prior
to giving the sample. Participants were also required to com-
plete a diary as a record of their sampling schedule to assess
compliance. Saliva samples were obtained at baseline and
2 months after surgery and stored at −20 °C for analysis at a
later date. Cortisol levels were assessed using a time-resolved
immunoassay with fluorescence detection, at the University of
Dresden. The intra- and inter-assay coefficients of variation
were less than 4 %. Cortisol data were analysed by computing
three different measures. Extreme outliers more than three
standard deviations from themeanwere removed. The cortisol
awakening response represents the difference between the
sample taken on awakening and 30 min later. To generate a
valid awakening response relies on the waking sample being
obtained without a delay, since otherwise the magnitude of the
response will be masked [30]. Participants who reported giv-
ing their first sample more than 15 min after awakening were
excluded from analyses [31]. The estimated AUCwith respect
to ground was generated as an approximation of total cortisol
output over the day [32]. The slope of cortisol decline over the
day was calculated as the reduction in cortisol per hour, using
regression methods. The slope excluded the 30-min post-
awakening sample, as is usual with these data [33].
Covariates: Sociodemographic, Mood and Clinical Measures
Socioeconomic status (SES) was assessed using yearly house-
hold income divided into five categories ranging from <£10,
000 per year to >£40,000 per year. Education was assessed by
asking participants to report their highest educational qualifi-
cation attained; this was used to categorise participants into
secondary education or lower and higher education and above.
Pre-operative smoking was assessed, and body mass index
(BMI) was measured at the pre-operative clinic appointment
and calculated using the standard formula (kg/m2).
The Beck Depression Inventory (BDI) [34] was used to
measure depression symptoms at baseline. It is a 21-item
questionnaire which asks the respondent to reflect on how
they have been feeling over the past 2 weeks. Ratings
were summed, with higher scores indicating greater emo-
tional disturbance, with a range of 0 to 63 (Cronbach’s
α=0.85).
Clinical risk was assessed using the European System for
Cardiac Operative Risk Evaluation (EuroSCORE) [35]. This
composite measure includes pre-surgical risk factors (e.g. age,
sex and serum creatinine), cardiovascular risk factors (e.g.
pulmonary hypertension and recent myocardial infarct) and
operative risk factors (e.g. non-isolated CABG and surgery
on the thoracic aorta). Items were scored in accordance with
the ‘logistic EuroSCORE’ method to generate a percentage
mortality risk estimate; further details can be found on the
E u r o S CORE w e b s i t e ( www. e u r o s c o r e . o r g /
logisticEuroSCORE.htm). Cardiovascular history, clinical
factors during admission and management were also
obtained from clinical notes. In addition, the number of
grafts a participant received and whether they underwent
cardiopulmonary bypass (yes/no) were also recorded.
History of diabetes was also taken from medical notes.
Participants were asked to report any long-standing illnesses
prior to surgery, and these were summed to capture chronic
illness burden.
Statistical Analysis
MoCA scores were treated as a binary variable (<26/≥26)
since this is a clinically pertinent cutoff with high sensitivity
and specificity to detect mild cognitive impairment and risk of
dementia [29]. Missing data on biomarkers meant that some
analyses were performed on a reduced sample size. Of all
participants, baseline and post-CABG IL-6 were available
for 135, hs-CRP was available for 136 and cortisol AUC
was available for 131. Descriptive statistics describe the 193
participants who provided full baseline data and follow-up
blood and/or saliva. Paired sample t tests were used to exam-
ine change in biomarkers over time. Associations between
variables were assessed using Pearson’s correlations for con-
tinuous data and independent t tests and chi-squared tests for
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categorical data. Multiple linear regression was used to exam-
ine the relationship between pre-operative cognitive function
and post-operative inflammatory and cortisol responses. The
assumptions of regression models were assessed, including
homoscedasticity, leverage points, standardised residuals and
multicollinearity; all results were within the acceptable range.
The independent variables in analyses were baseline scores on
the MoCA, and the dependent variables were IL-6, hs-CRP
and cortisol AUC. Covariates were selected on a prioi knowl-
edge. Variables were entered into models in steps. The first
model controlled for social-behavioural variables, namely ed-
ucation, household income, smoking status and BMI, and
mood and clinical variables, namely depression, cardiopulmo-
nary bypass use, number of grafts, chronic illness burden,
diabetes and EuroSCORE. Age and sex are included in
EuroSCORE, so were not entered separately to avoid double
adjustment. The baseline values of each respective biomarker
were also included in the first step. The second step included
MoCA scores to the model. All clinical variables fell within
the expected clinical range for our sample demographic [36,
37]. Follow-up IL-6 and baseline and follow-up CRP values
were non-normally distributed, but since log transformation
did not rectify this and since the conditions of regression were
not violated, raw data were used in the analyses. Secondary
analyses were performed to examine the dose–response rela-
tionship, controlling for covariates. Since the MoCA data
were skewed in favour of normal cognitive function, we cre-
ated a quintile variable. The quintile cutpoints were MoCA
scores 23, 25, 27 and 28. Variance inflation factor values were
generated for all regression models to assess multicollinearity;
all were within the acceptable range. Cortisol slope
(β=−0.065, p=0.419) and awakening response (β=0.095,
p=0.328) were not associated with cognitive function in uni-
variate models, and therefore, the results are not reported here.
All analyses were conducted using SPSS version 21. Two-
tailed tests were used throughout and the significance level
was set at p<0.05, although exact significance levels are
reported.
Results
Table 1 summarises the characteristics of the sample. The
sample had an age range between 44 and 87 years, was pre-
d om i n a n t l y m a l e ( 9 0 . 7 % ) a n d o v e r w e i g h t
(BMI>25=84.5 %). Participants came from a variety of in-
come backgrounds. The majority of participants were hyper-
tensive, and just over 20 % of participants were diabetic. The
majority of participants had on-pump cardiopulmonary by-
pass surgery in isolation, but 43 underwent combined
CABG plus valve replacement surgery. Most participants
were within the normal range for depression symptoms on
the BDI, but about one third (35.2 %) of participants scored
>10 at baseline. Approximately 60 % of participants scored
above the cutoff of 26 on the MoCA, which indicates normal
cognitive functioning. Plasma IL-6 (t=−35.320, p<0.001)
and hs-CRP (t=−11.607, p<0.001) levels increased signifi-
cantly from baseline to follow-up, whilst cortisol AUC
(t=0.550, p=0.583) responses did not change over time on
average. Neither IL-6 nor hs-CRP responses were associated
with cortisol at baseline or follow-up.
Table 1 Demographic, clinical and biological characteristics of the
sample (N= 193)
Characteristic Mean ± SD
or N (%)
Age (years) 67.47 ± 8.83
Female 18 (9.4)
Ethnicity—White British/white other 172 (89.1)
Education
Secondary or lower 143 (74.1)
Higher education or degree 50 (25.9)
BMI (kg/m2) 28.84 ± 4.18
Smoker 15 (7.8)
Yearly household income
<£10,000 30 (15.6)
£10,000–19,999 56 (29.2)
£20,000–29,999 43 (22.4)
£31,000–£40,000 27 (14.1)
>£40,000 36 (18.8)
Cognitive function (MoCA) <26 77 (40.1)
BDI score 8.48 ± 6.16
Co-morbidities
Chronic illness burden 0.44 ± 0.67
Diabetes 42 (21.9)
Hypertension 153 (79.7)
Pulmonary disease 12 (6.3)
Neurological disorder 15 (7.8)
Extracardiac arteriopathy 15 (7.8)
Clinical factors
Logistic EuroSCORE (%) 4.19 ± 2.80
CABG in isolation 150 (78.1)
Number of grafts 3.04 ± 1.15
On-pump 148 (77.1)
Biomarkers
Baseline IL-6 (pg/mL)* 5.23 ± 1.72
In-hospital (post-CABG) IL-6 (pg/mL)* 99.64 ± 31.45
Baseline hs-CRP (mg/dL)** 8.63 ± 9.72
In-hospital (post-CABG) hs-CRP (mg/dL)** 66.93 ± 60.87
Baseline cortisol AUC (nmol/l)*** 9131.59± 2577.38
Two month post-CABG cortisol
AUC (nmol/l)***
8955.78± 3532.29
*N= 135, **N = 136, ***N= 131
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Cognitive Function and Inflammatory Responses
Figure 1 shows the change in IL-6 over time by MoCA score.
There was no significant difference between groups at base-
line (t = −0.542, p = 0.589), but after surgery (t = 2.506,
p=0.013), there was a significant difference. Specifically,
those scoring <26 on the MoCA (mean 107.54, standard de-
viation 31.67) had higher IL-6 concentrations than those with
≥26 MoCA scores (mean 94.04, standard deviation 30.24) in
the days after CABG surgery. Table 2 displays the regression
coefficients for the model predicting post-operative IL-6 re-
sponses measured after surgery. Baseline MoCA score was a
significant predictor of greater IL-6 (β=−0.212, p=0.021),
independent of covariates. The association was negative such
that pre-operative low cognitive functioning was predictive of
greater IL-6 responses after surgery. The only other significant
predictor in the final model was baseline IL-6 (β=0.273,
p=0.003). The addition of MoCA to the model increased
the variance explained by 3.9 %; this was a significant contri-
bution (p=0.021). The final model accounted for 14.5 % of
the variance. Secondary analyses to examine the dose–re-
sponse relationship between cognitive function and IL-6
showed MoCA quintile to be a significant predictor of IL-6
response after surgery (β = −0.198, confidence interval
(CI) = −8.360–−0.216, p = 0.039) after controlling for
covariates.
In analyses to predict post-operative hs-CRP, baseline
MoCA score (β=0.064, p=0.457) was not a significant pre-
dictor in basic models controlling for age and sex, and there-
fore, fully adjusted models were not performed.
Cognitive Function and Cortisol AUC Responses
Figure 2 shows the change in cortisol AUC over time by
MoCA score. There was no significant difference between
groups at baseline (t = 1.487, p = 0.139), but differences
emerged after surgery (t= 2.640, p= 0.009). Specifically,
those scoring <26 on the MoCA (mean 9922.33, standard
deviation 4164.34) had a higher cortisol AUC than those with
≥26 MoCA scores (mean 8299.03, standard deviation
2876.36) 2 months after CABG surgery. Table 3 displays the
regression coefficients for the model predicting post-operative
cortisol AUC responses measured 2 months after surgery.
Baseline MoCA score was a significant predictor of greater
cortisol AUC (β=−0.179, p=0.044), independent of covari-
ates. The association was negative such that pre-operative low
cognitive functioning was predictive of greater cortisol AUC
responses after surgery. The other significant predictors in the
final model were smoking (β = 0.192, p = 0.023),
EuroSCORE (β = 0.323, p = 0.001) and baseline cortisol
AUC (β=0.267, p=0.003). The addition of MoCA to the
model increased the variance explained by 2.6 %; this was a
significant contribution (p=0.044).The final model accounted
for 25.5 % of the variance. Secondary analyses to examine the
dose–response relationship between cognitive function and
IL-6 showed MoCA quintiles to be a borderline significant
predictor of cortisol AUC responses after surgery
(β=−0.176, CI=−906.318–−0.370, p=0.050) after control-
ling for covariates.
Discussion
The results of these analyses show that low cognitive func-
tioning prior to surgery is predictive of impaired biological
responses following CABG, including a heightened IL-6 re-
sponse during the in-hospital stay and greater cortisol output
up to 2 months after surgery. These results were supported in
analyses using quintile MoCA scores to predict IL-6 and cor-
tisol AUC responses, indicating a dose–response relationship.
Pre-operative cognitive functioning was not associated with
hs-CRP following surgery. This is the first study to our knowl-
edge that has examined the prospective association between
pre-operative cognitive functioning and biological responses
to CABG surgery.
We found that approximately 40 % of participants prior to
CABG surgery had low cognitive functioning as measured on
the MoCA. This is in line with data from an Australian study
which reported cognitive impairment in 35 % of CABG pa-
tients prior to surgery, as compared with healthy controls [5].
Variation in cardiac and demographic risk factors are likely to
contribute to differences in the prevalence rates reported
across different studies; however, our findings corroborate
the observation that low levels of cognitive functioning are
common in this patient group.
Previous studies have shown a relationship between cogni-
tive functioning and inflammation. For example, Roberts and
colleagues [13] performed a case–control study in which
N.B. Bars indicate standard error of the mean.  
Baseline to post-CABG IL-6 (t = 2.506, p = 0.013). 
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inflammatory markers were compared in people with and
without mild cognitive impairment. These authors reported
that elevated levels of plasma CRP were significantly associ-
ated with mild cognitive impairment. In our study, we were
able to assess the prospective association between cognition
and inflammation and found that low cognitive function pro-
motes increased inflammation in response to CABG surgery.
There is a scarcity of research investigating inflammation and
cognition in cardiac patients. A longitudinal study using par-
ticipants taking part in the MacArthur Studies of Successful
Ageing also reported a negative association between cognitive
functioning and IL-6 over time, although this was a non-
clinical sample and therefore not directly comparable to our
findings [15]. In our study, we only found evidence for low
cognitive performance being associated with IL-6 and not
CRP. The reason for this is not clear, although one possibility
is that of timing. IL-6 is secreted by T cells and macrophages
as part of the initial immune response and triggers the release
of CRP from the liver. By measuring IL-6 and CRP at the
same time, we may have captured these markers at different
points in their decline towards baseline values. However, our
findings warrant replication in further, large-scale studies of
cardiac patients. Cognitive function explained 3.9 % of vari-
ance in IL-6 over and above other clinical, demographic and
mood variables. We believe our findings to be of clinical rel-
evance in that the heightened inflammation we observed in
Table 2 Multiple regression on
baseline cognitive functioning
predicting post-operative IL-6
(N = 135)
Model B SE ß 95 % CI P value
Step 1
Education 2.056 6.725 0.028 −11.256–15.369 0.760
Household income −2.876 2.115 −0.124 −7.063–1.310 0.176
Smoking status −3.426 9.959 −0.031 −23.140–16.287 0.731
BMI 0.677 0.653 0.093 −0.616–1.970 0.302
Baseline depression symptoms (BDI) 0.003 0.417 0.001 −0.823–0.829 0.994
Cardiopulmonary bypass 1.764 6.764 0.024 −11.625–15.154 0.795
Number of grafts −0.659 2.539 −0.023 −5.685–4.367 0.796
Chronic illness burden −6.894 6.077 −0.141 −18.923–5.135 0.259
Diabetes −2.414 8.973 −0.033 −20.176–15.348 0.788
EuroSCORE −0.129 1.060 −0.012 −2.227–1.969 0.903
Baseline IL-6 4.841 1.672 0.265 1.531–8.150 0.004
Step 2
Education 3.131 6.622 0.042 −9.978–16.239 0.637
Household income −1.467 2.163 −0.063 −5.748–2.814 0.499
Smoking status −5.360 9.817 −0.049 −24.793–14.073 0.586
BMI 0.443 0.649 0.061 −0.843–1.728 0.497
Baseline depression symptoms (BDI) −0.040 0.410 −0.009 −0.853–0.772 0.922
Cardiopulmonary bypass 2.061 6.645 0.028 −11.093–15.216 0.757
Number of grafts −1.338 2.511 −0.048 −6.309–3.632 0.595
Chronic illness burden −6.478 5.972 −0.133 −18.299–5.344 0.280
Diabetes −2.212 8.814 −0.030 −19.660–15.237 0.802
EuroSCORE −0.249 1.042 −0.022 −2.313–1.814 0.811
Baseline IL-6 4.974 1.643 0.273 1.721–8.227 0.003
Baseline MoCA score −13.456 5.739 −0.212 −24.818–−2.094 0.021
NB step 1 R2 = 0.107, step 2 R2 = 0.145, ΔR2 = 0.039, p= 0.021
N.B. Bars indicate standard error of the mean.  
Baseline to post-CABG IL-6 (t = 2.640, p = 0.009). 
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low cognitive function participants may in turn lead to phe-
nomena that produce poorer recovery, such as slower wound
healing or infection, or indeed, it could be important to later
cardiovascular morbidity in the same way it is in acute coro-
nary syndrome patients [38, 39]. Greater inflammation after
CABG has previously been associated with greater morbidity
including increased risk of atrial fibrillation [40], poorer lung
function [41] and even death [42]. This hypothesis requires
further testing using other longer-term CABG morbidity end
points.We have shown in other analyses that the magnitude of
acute inflammatory responses following surgery predicts later
depressive symptoms [43] and length of hospital stay [44].
Previous research has shown that cognitive function, partic-
ularly memory, and cortisol levels are related [45–47]. Whilst
this literature is well established, few studies have investigated
these effects in CABG patients. One study examined 166 pa-
tients after CABG surgery and found that higher levels of serum
cortisol on the morning after surgery was associated with poorer
cognitive performance 7 days later [27]. Salivary cortisol has
been found to increase greatly after non-cardiac surgery in as-
sociation with post-operative cognitive dysfunction [48], so this
effect might not be specific to CABG surgery patients. In our
study, we found that low pre-operative cognitive function pre-
dicts greater cortisol output across the day up to 2 months after
CABG surgery. Indeed, cognitive function predicted 2.6 % of
variance in cortisol AUC responses over and above covariates.
There is limited evidence for the detrimental effects of elevated
cortisol in this patient group; however, there is some evidence
that it is associated with poorer lung function [41] and increased
risk of delirium [49]. Moreover, we recently showed that flatter
cortisol slopes prior to CABGwere associated with greater mor-
tality and major adverse events up to 2.68 years after surgery
[50]. We found an effect for cortisol AUC but not for cortisol
awakening response or slope. The reason for this is not entirely
clear, although previous work has suggested that the awakening
response in particular is highly influenced by situational factors
[51], making it a less reliable indicator of trait responses. Further
research is needed to understand whether these effects persist in
the longer term and whether such elevations in cortisol translate
into greater clinical risk in these patients.
Interestingly, we showed that not only those participants
falling below the cutoff for mild cognitive impairment were
Table 3 Multiple regression on
baseline cognitive functioning
predicting post-operative cortisol
AUC (N= 131)
Model B SE ß 95 % CI P value
Step 1
Education 118.329 672.515 0.015 −1213.318–1449.976 0.861
Household income 174.029 242.522 0.064 −306.188–654.246 0.474
Smoking status 2582.061 1170.171 0.186 265.006–4899.116 0.029
BMI 125.660 92.776 0.123 −58.047–309.366 0.178
Baseline depression symptoms
(BDI)
−58.117 52.412 −0.093 −161.899–45.665 0.270
Cardiopulmonary bypass 593.646 724.374 0.069 −840.686–2027.978 0.414
Number of grafts −99.561 253.989 −0.033 −602.484–403.362 0.696
Chronic illness burden 150.842 670.022 0.024 −1175.868–1477.552 0.822
Diabetes −258.176 983.143 −0.028 −2204.896–1688.545 0.793
EuroSCORE 405.255 114.325 0.338 178.880–631.630 0.001
Baseline cortisol AUC 0.401 0.119 0.293 0.166–0.637 0.001
Step 2
Education −114.482 673.528 −0.015 −1448.250–1219.286 0.865
Household income 338.467 252.597 0.124 −161.744–838.678 0.183
Smoking status 2667.772 1155.725 0.192 379.121–4956.423 0.023
BMI 99.524 92.464 0.097 −83.580–282.627 0.284
Baseline depression symptoms
(BDI)
−56.219 51.740 −0.090 −158.678–46.239 0.279
Cardiopulmonary bypass 492.464 716.679 0.057 −926.754–1911.683 0.493
Number of grafts −162.305 252.570 −0.054 −662.462–337.852 0.522
Chronic illness burden 195.304 661.672 0.032 −1114.986–1505.595 0.768
Diabetes −333.939 971.075 −0.036 −2256.932–1589.053 0.732
EuroSCORE 386.407 113.217 0.323 162.206–610.608 0.001
Baseline cortisol AUC 0.366 0.119 0.267 0.131–0.601 0.003
Baseline MoCA score −1279.758 627.825 −0.179 −2523.023–−36.494 0.044
NB step 1 R2 = 0.229, step 2 R2 = 0.255, ΔR2 = 0.026, p= 0.044
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at risk of poorer biological responses but also that cognition
and inflammation and cortisol were associated in a graded
fashion, indicative of a dose–response relationship. This sug-
gests that even amongst participants within the normal range
of cognitive performance, those scoring at the lower end of the
scale had worse biological responses than those at the higher
end of the scale. More work is needed to understand the use of
cutoffs in this patient group and the benefits of early identifi-
cation of patients with less than optimal cognitive functioning.
In the current study, heightened inflammatory and neuroen-
docrine activity after the stress of CABG surgery seen in pa-
tients with lower cognitive functioning suggest that there may
be disruption of the HPA axis in some patients. The human
stress response involves activation of the HPA axis, the subse-
quent release of cortisol and simultaneous elevation of inflam-
matory cytokines [52]. However, wewere unable to support the
association between cortisol and inflammation using our data,
perhaps due to the temporal differences in collection of blood
and saliva samples. Further research examining these bio-
markers in CABG patients is needed. In addition, non-
biological mechanisms also warrant further examination since
behavioural pathways including the role of physical activity,
adherence to medications, diet and alcohol consumption may
also be relevant. Psychological mechanisms are also likely to
be important. It is possible that those with cognitive impairment
are less likely to employ adaptive coping responses (e.g. social
support) to a stressor such as CABG surgery, resulting in great-
er perceived stress and in turn poorer biological responses to
surgery. These pathways require further study as potential me-
diators or moderators of this relationship.
There are several strengths to our study. The longitudinal
design of the ARCS study allows for the temporal relationship
between cognitive function and biological responses to surgery
to be analysed. Moreover, the large range of psychosocial and
clinical data collected from the ARCS participants has allowed
us to control for multiple covariates that might confound the
association between cognition and biomarkers. However, there
are also a number of limitations. Firstly, we have relied on a
short, global assessment of cognitive function that does not
allow us to study the relationship between different cognitive
domains and inflammation and cortisol. In addition, cognitive
function was only assessed pre-operatively, so it was not possi-
ble to assess the effect of cognitive deterioration from before to
after the surgical procedure. Moreover, missing data on the bi-
ological measures meant that we had to perform some of our
analyses on a reduced sample size. The ARCS study had a
relatively homogenous sample, being predominately male and
of White ethnic origin making generalisation to other groups
difficult. Only 9.4 % of our samples were female. This male
majority is characteristic of the CABG surgical population more
generally, with men more likely to receive a revascularisation
procedure than women in the UK. However, we included sex in
all analyses as a covariate in order to address this issue.
In conclusion, we found that low cognitive functioning
prior to CABG surgery was associated with greater IL-6 re-
sponses in the days following surgery and greater cortisol
output up to 2 months later. The poorer biological responses
observed in these patients may help explain the link between
cognitive decline and cardiovascular pathology.
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